The truncated C-terminal E2 (E2-TR) protein of bovine papillomavirus (BPV) type-1 is a transactivator that modulates transcription in vivo and in vitro in a manner distinct from the E2-TA and E8E2 gene products

被引:5
|
作者
Lace, Michael J. [1 ,2 ]
Ushikai, Masato [1 ]
Yamakawa, Yasushi [1 ]
Anson, James R. [1 ]
Ishiji, Takaoki [3 ]
Turek, Lubomir P. [1 ,2 ]
Haugen, Thomas H. [1 ,2 ]
机构
[1] Vet Affairs Healthcare Syst, Iowa City, IA 52246 USA
[2] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA
[3] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan
关键词
Transcription; Papillomavirus; Gene expression; Inhibition; Cooperative activation; DNA-BINDING DOMAIN; ACTIVATION DOMAINS; CONSTITUTIVE ENHANCER; FUNCTIONAL-ANALYSIS; REPLICATION; REPRESSOR; INHIBITION; PROMOTER; SP1; VIRUS;
D O I
10.1016/j.virol.2012.03.020
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The E2 open reading frame of bovine papillomavirus (BPV)-1 encodes a 410 amino acid (aa) transcriptional activator, E2-TA, and collinear polypeptides-E2-TR (243 aa) and E8E2 (196 aa). E8E2 and E2-TR share the DNA-binding domain of E2-TA, and both have been defined as transcriptional repressors. Although purified E2-TR and E8E2 proteins specifically bound E2 sites with similar affinities, only the E2-TR stimulated transcription. Here we show that E2-TR trans-activates E2-dependent promoters 5 to 10-fold in cooperation with cellular factors and in a dose-dependent fashion in epithelial cells and fibroblasts of animal or human origin while E2-TA activated > 100-fold and the E8E2 had no effect. However, in contrast to E2-TA. E2-TR activated transcription from a promoter-proximal position. E2-TR also partially inhibited the BPV-1 P89 or heterologous promoters whereas E8E2 led to complete repression. Thus, the BPV-1 E2-TR modulates viral gene expression in a manner distinct from other E2 proteins. Published by Elsevier Inc.
引用
收藏
页码:99 / 111
页数:13
相关论文
共 50 条
  • [1] THE BOVINE PAPILLOMAVIRUS TYPE-1 (BPV1) REPLICATION PROTEIN E1 MODULATES TRANSCRIPTIONAL ACTIVATION BY INTERACTING WITH BPV1 E2
    LEMOAL, MA
    YANIV, M
    THIERRY, F
    JOURNAL OF VIROLOGY, 1994, 68 (02) : 1085 - 1093
  • [2] THE E2 TRANSACTIVATOR OF BOVINE PAPILLOMAVIRUS TYPE-1 IS EXPRESSED FROM MULTIPLE PROMOTERS
    VAILLANCOURT, P
    NOTTOLI, T
    CHOE, J
    BOTCHAN, MR
    JOURNAL OF VIROLOGY, 1990, 64 (08) : 3927 - 3937
  • [3] The bovine papillomavirus E2 transactivator is stimulated by the E1 initiator through the E2 activation domain
    Parker, LM
    Harris, S
    Gossen, M
    Botchan, MR
    VIROLOGY, 2000, 270 (02) : 430 - 443
  • [4] Distinct roles of two binding sites for the bovine papillomavirus (BPV) E2 transactivator on BPV DNA replication
    Gillette, TG
    Borowiec, JA
    JOURNAL OF VIROLOGY, 1998, 72 (07) : 5735 - 5744
  • [5] Control of viral replication and transcription by the papillomavirus E8∧E2 protein
    Dreer, Marcel
    de Poel, Saskia van
    Stubenrauch, Frank
    VIRUS RESEARCH, 2017, 231 : 96 - 102
  • [6] Amino acids critical for the functions of the bovine papillomavirus type 1 E2 transactivator
    Brokaw, JL
    Blanco, M
    McBride, AA
    JOURNAL OF VIROLOGY, 1996, 70 (01) : 23 - 29
  • [7] Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin
    Skiadopoulos, MH
    McBride, AA
    JOURNAL OF VIROLOGY, 1998, 72 (03) : 2079 - 2088
  • [8] EVIDENCE FOR COOPERATIVITY BETWEEN E2 BINDING-SITES IN E2 TRANS-REGULATION OF BOVINE PAPILLOMAVIRUS TYPE-1
    SPALHOLZ, BA
    BYRNE, JC
    HOWLEY, PM
    JOURNAL OF VIROLOGY, 1988, 62 (09) : 3143 - 3150
  • [9] Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo
    Kurg, Reet
    Uusen, Piia
    Sepp, Toomas
    Sepp, Mari
    Abroi, Aare
    Ustav, Mart
    VIROLOGY, 2009, 386 (02) : 353 - 359
  • [10] Association of bovine papillomavirus E2 protein with nuclear structures in vivo
    Kurg, R
    Sild, K
    Ilves, A
    Sepp, M
    Ustav, M
    JOURNAL OF VIROLOGY, 2005, 79 (16) : 10528 - 10539